The Hydroxyzine Pamoate Capsules, cataloged under National Stock Number 6505-01-156-2032, is classified within Federal Supply Class 6505 (No Item Name Available) of the Medical, Dental, and Veterinary Equipment group. The primary manufacturer of record is Teva Pharmaceuticals Usa, Inc.. Government technical data includes 3 verified specifications, sourced from the Federal Logistics Information System (FLIS). This item has 6 commercial cross-references from 5 manufacturers, enabling identification through both NSN and commercial part number lookups. 4 verified substitutes exist in the FLIS interchangeability database. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-156-2032 |
| Primary Part Number | NDC00555-0302-02 |
| Item Name | Hydroxyzine Pamoate Capsules |
| FSC / FSG | 6505 / 65 — No Item Name Available |
| Manufacturer | Teva Pharmaceuticals Usa, Inc. |
| Status | ACTIVE |
| Primary Container Type | BOTTLE |
| Capsule Primary Container Content Quantity | 100.000 |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Acquisition Status | ACTIVE |
| HAZMAT | No |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| VISTARIL | Pfizer Inc (USA) |
| NDC00555-0302-02 PRIMARY | Teva Pharmaceuticals Usa, Inc. (USA) |
| NDC14539-0675-01 PRIMARY | Heritage Pharmaceuticals Inc. Dba Avet Pharmaceuticals Inc. Div Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc (USA) |
| VISTARIL CAPSULES | Pfizer Inc (USA) |
| NDC00591-0801-01 | Actavis Pharma, Inc. (USA) |
| NDC59762-5420-01 | Greenstone Llc (USA) |
NSN 6505-01-156-2032 is a Hydroxyzine Pamoate Capsules, manufactured by Teva Pharmaceuticals Usa, Inc., classified under FSC 6505 (No Item Name Available). Status: active.
NSN 6505-01-156-2032 has 6 cross-referenced part numbers: VISTARIL (Pfizer Inc), NDC00555-0302-02 (Teva Pharmaceuticals Usa, Inc.), NDC14539-0675-01 (Heritage Pharmaceuticals Inc. Dba Avet Pharmaceuticals Inc. Div Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc), VISTARIL CAPSULES (Pfizer Inc), NDC00591-0801-01 (Actavis Pharma, Inc.) and 1 more.
There are 4 known substitutes for 6505-01-156-2032: 6505-00-765-0823, 6505-00-765-0826, 6505-01-042-6501 and 1 more. Verify interchangeability with system specifications before substitution.
Key specifications for NDC00555-0302-02: Primary Container Type: BOTTLE; Capsule Primary Container Content Quantity: 100.000; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Special Features: 50 MG HYDROXYZINE HYDROCHLORIDE EQUIVALENT. 5 total characteristics are documented in the Federal Logistics Information System.